Jump to main content
Jump to site search

Issue 3, 2012
Previous Article Next Article

Arylsulfonamides as inhibitors for carbonic anhydrase: prediction & validation

Author affiliations

Abstract

Arylsulfonamide derivatives are widely studied high affinity inhibitors of the isozyme human carbonic anhydrase II (hCA II). From molecular dynamics simulations and MM-GBSA calculations, reliable (R = 0.89) relative binding free energies are determined for 17 previously experimentally characterized protein–ligand complexes. Decomposition of these energies led to the identification of critical amino acid residues with a significant contribution to the affinity towards the ligands. In particular, Leu198 was predicted as a key residue and was subjected to computational mutagenesis. This prediction was verified experimentally by producing hCA II mutants L198A, L198F and L198Q and determining the resulting affinities towards inhibitor 1. The computed vs. experimental energies are in good agreement thus suggesting that the force field parameters reported herein are useful for the in silico design of a wider range of carbonic anhydrase inhibitors.

Graphical abstract: Arylsulfonamides as inhibitors for carbonic anhydrase: prediction & validation

Back to tab navigation

Supplementary files

Publication details

The article was received on 02 Sep 2011, accepted on 14 Nov 2011 and first published on 06 Dec 2011


Article type: Edge Article
DOI: 10.1039/C1SC00628B
Citation: Chem. Sci., 2012,3, 690-700
  •   Request permissions

    Arylsulfonamides as inhibitors for carbonic anhydrase: prediction & validation

    M. Schmid, E. S. Nogueira, F. W. Monnard, T. R. Ward and M. Meuwly, Chem. Sci., 2012, 3, 690
    DOI: 10.1039/C1SC00628B

Search articles by author

Spotlight

Advertisements